Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126655281 | 12665528 | 1 | I | 20160808 | 20160818 | 20160818 | EXP | IT-PRINSTON PHARMACEUTICAL INC.-2016PRN00215 | PRINSTON PHARMACEUTICAL | FOIS C, RASSU AL, SECHI E, ET AL.. UNPREDICTABLE SEIZURE-WORSENING INDUCED BY LEVETIRACETAM MONOTHERAPY IN A PATIENT WITH FOCAL CORTICAL DYSPLASIA TYPE II. EUR J NEUROL. 2016;23(SUPPL. 2):172-173 | 0.00 | Y | 0.00000 | 20160818 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126655281 | 12665528 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 15 MG, 1X/DAY | Y | 78106 | 15 | MG | QD | ||||||
| 126655281 | 12665528 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 30 MG, 1X/DAY | Y | 78106 | 30 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126655281 | 12665528 | 1 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126655281 | 12665528 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126655281 | 12665528 | Epilepsy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |